Based on current data, GLP-1s appear generally well tolerated in people with IBD, but we do not yet have large, long-term trials in people with UC, so I tell patients we should decide together, case by case, based on their disease activity, nutritional status, and other health conditions, Dr
Aside from RUO sales by chemical companies mostly marketing directly to physician practices and/or consumers for human use which is not permitted, others try to operate at risk in this somewhat Grey Market
Tirzepatide Side Effects Tirzepatide may cause side effects, especially when treatment begins or after a dose increase
Some patients find BPC-157 helpful during flares for inflammation
I dont usually lead with this when introducing myself